Centessa Pharmaceuticals PLC ADR (CNTA) — Financial Flexibility Index
Centessa Pharmaceuticals PLC ADR (CNTA) has a Financial Flexibility Index of -0.47x as of March 2026. Free cash flow of $-72.22 Million (operating CF $-72.22 Million minus capex $0.00) represents 0% of total liabilities ($154.41 Million). Check CNTA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Centessa Pharmaceuticals PLC ADR Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Centessa Pharmaceuticals PLC ADR across 7 annual periods. See CNTA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Centessa Pharmaceuticals PLC ADR (2019–2025)
Year-by-year free cash flow to debt coverage for Centessa Pharmaceuticals PLC ADR. For the full company profile including market capitalisation, see CNTA market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.20x | $-193.45 Million | $-193.82 Million | $160.63 Million | ▼ -48.6% |
| 2024 | -0.81x | $-142.02 Million | $-142.06 Million | $175.25 Million | ▲ +37.3% |
| 2023 | -1.29x | $-160.17 Million | $-160.34 Million | $124.00 Million | ▲ +30.0% |
| 2022 | -1.84x | $-199.41 Million | $-200.55 Million | $108.14 Million | ▼ -87.3% |
| 2021 | -0.98x | $-135.96 Million | $-136.14 Million | $138.08 Million | ▲ +18.7% |
| 2020 | -1.21x | $-10.44 Million | $-10.63 Million | $8.62 Million | ▼ -30.3% |
| 2019 | -0.93x | $-5.64 Million | $-5.83 Million | $6.07 Million | — |